Drug-Induced Liver Injury Caused by Capecitabine: A Case Report and a Literature Review.
Ontology highlight
ABSTRACT: Chemotherapy is widely used in cancer treatment, and the drug Capecitabine is often used in treatment of breast cancer and usually well-tolerated. Toxicity from Capecitabine typically involves hand-foot syndrome, fatigue, nausea, reduced appetite, and diarrhea, while severe liver toxicity is rarely seen. We present a case of a 63-year-old female with metastatic breast cancer, without liver metastasis, who developed a severe drug-induced liver injury (DILI) with critically elevated liver enzyme levels as reaction to Capecitabine treatment with seemingly no evident explanation as to why. The patient had a RUCAM score of 7 and a Naranjo score of 6 implying that this association between Capecitabine and the liver injury falls into the "probable" category. The patient recovered completely and w
SUBMITTER: Hussein M
PROVIDER: S-EPMC10293942 | biostudies-literature | 2023 Jan-Dec
REPOSITORIES: biostudies-literature
ACCESS DATA